The U.S. Food and Drug Administration (FDA) has approved a new pill called Ibtrozi (taletrectinib) for treating a rare type of lung cancer known as ROS1-positive non-small cell lung cancer (NSCLC). New Lung Cancer Treatment Approved: Ibtrozi Targets ROS1-Positive NSCLC
What is ROS1-Positive Lung Cancer?
This is a special type of lung cancer that affects about 2% of people with lung cancer.It mostly happens in younger people and those who never smoked.It can spread to the brain, which makes it more dangerous.
What is Ibtrozi and How Does It Work?
Ibtrozi is a pill you take once a day.It targets a protein called ROS1, which helps cancer grow.The best part? It can also reach the brain and fight cancer that has spread there.
How Well Does It Work
For people who never took ROS1 medicine before: About 90% of patients got better or their cancer got smaller.
For people who tried other treatments before: Around 52%–62% still saw good results.
For patients with brain tumors: Ibtrozi worked well in the brain too, helping 63%–73% of patients.
Are There Any Side Effects?
Yes, like most medicines, there can be some side effects: Diarrhea, Nausea or vomiting, Dizziness,Feeling tired, Skin rash. But don’t worry—most people had only mild side effects, and only a few had to stop taking the pill.
How Much Does It Cost?
The price is about $29,500 per month (around ₹24 lakhs).The company, Nuvation Bio, is offering financial help to make it easier for patients to get the medicine.
Right now, Ibtrozi is approved in the USA only. It may soon be approved in other countries, including China.Other companies are also trying to make similar pills for ROS1 cancer.This means patients will have more choices in the future.
Ibtrozi is a new and powerful pill for treating a rare type of lung cancer.
It is Easy to take (just one pill a day).
Works well even in the brain.
Has fewer and mild side effects.
Gives new hope to patients.
Author
Discover more from SmartBangali
Subscribe to get the latest posts sent to your email.
Leave a Reply